Sakar has a robust infrastructure for carrying out research and development covering multiple therapeutic categories including analgesic, antipyretic, antibiotics, vitamins, caugh expectorants. A team of well trained scientists is working under able leadership of Dr.Guruprasad Vader, who has over 32 years of comprehensive industry experience in field of Research & Development. The team performance with encouraging outcomes has been recognised by Department of Scientific & Industrial Research (DSIR)under Ministry of Science & Technology, India. With proven expertise and recognition, Sakar further looks forward to opportunities pursuing researches with oncology products.
Comprehensive up-to-date Oncology R & D, ADL and F & D laboratories to partner services which include:
Chemical synthesis services for API intermediates and speciality chemicals in the most modern Research Development and manufacturing centre, which is equipped with batch type with 22 fume hoods and AI integrated flow chemistry based operation system with modern analytical back up facilities
The initial phase Contract Development Services can be offered in containment facilities designed for HPAPI, comprising of laboratory scale process development, non-infringing studies, impurities identification, isolation and characterisation, analytical method devolvement, accelerated stability studies and process validation with complete documentation (PDR) as per QBD concept for Lab development products
The next phase to Scale up Studies can be supported with detailed impurity profiling, stability studies, risk analysis studies and production from gram scale to kilo scale with all cGMP documentation in HPAPI containment area. Validation batches can be offered for both formulation devolvement as well as clinical trials. Area - API Plant gm scale & pilot area
The Standalone unit is to offer comprehensive Process development, analytical development, stability studies for finished dosages in contained formulation development lab. Formulation development studies as per the QBD Concept with complete documentation and PDR for any New Drug Delivery System for Solid dosage, liquid injection and lyophilised molecules (OSD & Injections area)
The Pilot Plant validation batches can be further taken up for Technology Transfer in contained cGMP facility. Sakar can subsequently offer the Commercial Production for finished formulations of solid, liquid injection & lyophilised injection in contained lines to help you achieve your objectives